These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 23332494)

  • 1. Effects of monoamine reuptake inhibitors in assays of acute pain-stimulated and pain-depressed behavior in rats.
    Rosenberg MB; Carroll FI; Negus SS
    J Pain; 2013 Mar; 14(3):246-59. PubMed ID: 23332494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of repeated treatment with monoamine-transporter-inhibitor antidepressants on pain-related depression of intracranial self-stimulation in rats.
    Legakis LP; Karim-Nejad L; Negus SS
    Psychopharmacology (Berl); 2020 Jul; 237(7):2201-2212. PubMed ID: 32382785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the triple monoamine uptake inhibitor amitifadine on pain-related depression of behavior and mesolimbic dopamine release in rats.
    Miller LL; Leitl MD; Banks ML; Blough BE; Negus SS
    Pain; 2015 Jan; 156(1):175-184. PubMed ID: 25599313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relief of Pain-Depressed Behavior in Rats by Activation of D1-Like Dopamine Receptors.
    Lazenka MF; Freitas KC; Henck S; Negus SS
    J Pharmacol Exp Ther; 2017 Jul; 362(1):14-23. PubMed ID: 28411257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pain- and analgesia-related manipulations on intracranial self-stimulation in rats: further studies on pain-depressed behavior.
    Pereira Do Carmo G; Stevenson GW; Carlezon WA; Negus SS
    Pain; 2009 Jul; 144(1-2):170-7. PubMed ID: 19435650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the δ opioid receptor agonist SNC80 on pain-related depression of intracranial self-stimulation (ICSS) in rats.
    Negus SS; Rosenberg MB; Altarifi AA; O'Connell RH; Folk JE; Rice KC
    J Pain; 2012 Apr; 13(4):317-27. PubMed ID: 22424913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of monoamine uptake inhibitors on pain-related depression of nesting in mice.
    Alexander KS; Rodriguez TR; Sarfo AN; Patton TB; Miller LL
    Behav Pharmacol; 2019 Sep; 30(6):463-470. PubMed ID: 30724802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of μ-opioid receptor agonists in assays of acute pain-stimulated and pain-depressed behavior in male rats: role of μ-agonist efficacy and noxious stimulus intensity.
    Altarifi AA; Rice KC; Negus SS
    J Pharmacol Exp Ther; 2015 Feb; 352(2):208-17. PubMed ID: 25406170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nicotinic acetylcholine receptor agonists in assays of acute pain-stimulated and pain-depressed behaviors in rats.
    Freitas KC; Carroll FI; Negus SS
    J Pharmacol Exp Ther; 2015 Nov; 355(2):341-50. PubMed ID: 26359313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the fatty acid amide hydrolase inhibitor URB597 on pain-stimulated and pain-depressed behavior in rats.
    Kwilasz AJ; Abdullah RA; Poklis JL; Lichtman AH; Negus SS
    Behav Pharmacol; 2014 Apr; 25(2):119-29. PubMed ID: 24583930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociable effects of the cannabinoid receptor agonists Δ9-tetrahydrocannabinol and CP55940 on pain-stimulated versus pain-depressed behavior in rats.
    Kwilasz AJ; Negus SS
    J Pharmacol Exp Ther; 2012 Nov; 343(2):389-400. PubMed ID: 22892341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel triple reuptake inhibitor JZAD-IV-22 exhibits an antidepressant pharmacological profile without locomotor stimulant or sensitization properties.
    Caldarone BJ; Paterson NE; Zhou J; Brunner D; Kozikowski AP; Westphal KG; Korte-Bouws GA; Prins J; Korte SM; Olivier B; Ghavami A
    J Pharmacol Exp Ther; 2010 Dec; 335(3):762-70. PubMed ID: 20864506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of 5-HT₂C receptors in effects of monoamine releasers on intracranial self-stimulation in rats.
    Bauer CT; Banks ML; Blough BE; Negus SS
    Psychopharmacology (Berl); 2015 Sep; 232(17):3249-58. PubMed ID: 26041338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of kappa opioids in an assay of pain-depressed intracranial self-stimulation in rats.
    Negus SS; Morrissey EM; Rosenberg M; Cheng K; Rice KC
    Psychopharmacology (Berl); 2010 Jun; 210(2):149-59. PubMed ID: 20101391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the noncompetitive N-methyl-d-aspartate receptor antagonists ketamine and MK-801 on pain-stimulated and pain-depressed behaviour in rats.
    Hillhouse TM; Negus SS
    Eur J Pain; 2016 Sep; 20(8):1229-40. PubMed ID: 26914635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the α2/α3-subtype-selective GABAA receptor positive allosteric modulator KRM-II-81 on pain-depressed behavior in rats: comparison with ketorolac and diazepam.
    Moerke MJ; Li G; Golani LK; Cook J; Negus SS
    Behav Pharmacol; 2019 Aug; 30(5):452-461. PubMed ID: 30640180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential tolerance to morphine antinociception in assays of pain-stimulated vs. pain-depressed behavior in rats.
    Altarifi AA; Negus SS
    Eur J Pharmacol; 2015 Feb; 748():76-82. PubMed ID: 25530266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociable effects of the kappa opioid receptor agonist nalfurafine on pain/itch-stimulated and pain/itch-depressed behaviors in male rats.
    Lazenka ML; Moerke MJ; Townsend EA; Freeman KB; Carroll FI; Negus SS
    Psychopharmacology (Berl); 2018 Jan; 235(1):203-213. PubMed ID: 29063139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of repeated treatment with methcathinone, mephedrone, and fenfluramine on intracranial self-stimulation in rats.
    Suyama JA; Banks ML; Negus SS
    Psychopharmacology (Berl); 2019 Mar; 236(3):1057-1066. PubMed ID: 30232529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of intracranial self-stimulation to evaluate abuse-related and abuse-limiting effects of monoamine releasers in rats.
    Bauer CT; Banks ML; Blough BE; Negus SS
    Br J Pharmacol; 2013 Feb; 168(4):850-62. PubMed ID: 22978626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.